Awards & Recognition
St. Joseph's Executive Leadership
History of St. Joseph's
Press Center and News
Research and Education
Sponsorship Request Application
Meet our Cancer Specialists: Jasmine Huang, MD | Michael Smith, MD
Norton Thoracic Institute (NTI) is a national leader in the prevention, early diagnosis, and treatment of thoracic cancers, including lung, esophageal, and gastric cancer.
These cancers are often aggressive and difficult to treat. According to the American Cancer Society, lung cancer causes more deaths in the U.S. every year than any other type of cancer, while one type of esophageal cancer—called adenocarcinoma—is now the fastest-growing type of cancer in the Western world. But there is hope. Physicians and clinical researchers are developing new ways to identify cancer in its early stages and treat it effectively. Researchers in labs around the world—including here at NTI—are getting closer to finding cures for these cancers.
We encourage you to learn all you can about your disease so you can partner with us in treating and managing your condition.
The experts at NTI care for patients with lung, esophageal, and gastric cancer using a three-pronged treatment approach designed to produce the best possible outcomes. This includes:
“We take a very aggressive approach to treating people at risk of lung, esophageal, or gastric cancer, as well as those who have been diagnosed with one of these diseases,” says Dr. Ross Bremner, director of Norton Thoracic Institute. “Early intervention drastically improves outcomes.”
Norton Thoracic Institute offers the following services to patients with thoracic cancer:
For more information about thoracic cancer services at Norton Thoracic Institute, please call 602.406.4000.